Keytruda did not significantly impact long-term health-related quality of life in stage 3 melanoma patients compared to placebo. Both Keytruda and placebo groups returned to baseline quality of life ...
Findings from a phase 2 trial showed improvements in relapse-free survival with an mRNA vaccine plus Keytruda compared with Keytruda alone in patients with high-risk resected melanoma. The combination ...
Doctors monitor Keytruda’s effectiveness using imaging tests like CT or MRI scans to check tumor size. (Sometimes tumors may appear larger initially due to a phenomenon called pseudoprogression.) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results